+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Imaging CRO Market - Global Forecast 2026-2032- Product Image
Molecular Imaging CRO Market - Global Forecast 2026-2032- Product Image
New

Molecular Imaging CRO Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123998
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The molecular imaging CRO market is evolving rapidly, providing critical support for precision-driven clinical trials as sponsors seek reliable data for pivotal decision-making. With dynamic operating environments and increasing protocol complexity, the demand for sophisticated contract research organizations in molecular imaging continues to grow.

Market Snapshot: Molecular Imaging CRO Growth and Drivers

The Molecular Imaging CRO Market grew from USD 3.24 billion in 2025 to USD 3.70 billion in 2026. It is expected to continue growing at a CAGR of 17.17%, reaching USD 9.84 billion by 2032. Growth is fueled by expanding pipelines in precision medicine, biomarker-guided oncology, and cell and gene therapy, elevating the strategic importance of imaging endpoints across global trials.

Scope & Segmentation Insights

  • Service Types: Comprehensive offerings now integrate project management, centralized reading, site qualification, quality oversight, and imaging manual development, streamlining communication and minimizing data variability.
  • Technological Modalities: PET/CT, PET/MR, SPECT, MRI, and CT, each with nuanced requirements for harmonization, logistics, and interpretability. Hybrid and multimodal workflows demand capabilities in digital pathology, circulating biomarkers, and real-world clinical data integration.
  • Study Phases: Early-phase imaging requires agility and close scientific collaboration, while later-stage trials prioritize scalable reading, inspection readiness, and global quality governance.
  • Therapeutic Areas: Key focus areas include oncology with its intense need for longitudinal tracking, neurology and cardiology emphasizing confounder management, and rare/inflammatory diseases where enrollment scarcity and site specialization drive network requirements.
  • Regions: Execution varies across the Americas, EMEA, and Asia-Pacific due to infrastructure maturity, regulatory complexities, and radiotracer logistics. Each region presents unique challenges in site onboarding, data protection, and supply continuity.
  • Sponsor Segments: Large pharmaceutical firms typically require global standardization, while smaller biotechs often prioritize speed, technical advice, and predictable deliverables.

Molecular Imaging CROs: Key Takeaways for Senior Decision-Makers

  • Molecular imaging CROs are redefining their role, transitioning from service vendors to scientific and operational partners capable of supporting early, quantitative clinical decisions.
  • Multimodal integration is the new norm as sponsors combine functional and molecular signals with digital biomarkers and real-world data, increasing technical requirements across studies.
  • Networked execution replaces single-center excellence. CROs invest in site training, centralized oversight, and real-time support to limit data drift in diverse, decentralized networks.
  • Automation and advanced analytics, including AI-assisted lesion detection and segmentation, are leveraged for consistency and efficiency, but always paired with human validation and strong change governance.
  • Resilient operations and risk management are priorities. Leaders select partners able to document sourcing strategies, proactively address supply challenges, and maintain strict quality under disruption.

Tariff Impact on Imaging CRO Operations in 2025

Anticipated United States tariffs for 2025 introduce new risks in procurement, equipment logistics, and cost structure. Imaging CROs are impacted directly and via site partners through potential delays in servicing, parts availability, and volatility in supply chains for key hardware and radiopharmaceutical logistics.

  • Equipment servicing and upgrades may become more costly or delayed, increasing the need for robust preventive maintenance and contingency systems.
  • Procurement conservatism may lead teams to favor modalities and components less exposed to tariff-related supply interruptions.
  • Budget transparency and clear contractual terms, including tariff pass-through and service-level agreements, are becoming critical to sponsor-CRO relationships.
  • Diversification in suppliers and logistics partners is accelerating, with an emphasis on alternate sites, couriers, and backup plans for radiotracer distribution.

Methodology & Data Sources

This analysis is grounded in comprehensive market mapping, executive interviews, company materials, and publicly available documentation. The research applies a triangulated approach, ensuring insights reflect operational reality across global imaging-enabled clinical research.

Why This Report Matters for Strategic Planning

  • Enables senior leaders to benchmark CRO capabilities and select partners aligned with trial complexity, therapeutic goals, and regional operating risks.
  • Supports proactive planning for tariff-driven disruptions by offering actionable guidance on sourcing, logistics, and change management.
  • Facilitates modernization of analytics and data governance without compromising quality, ensuring regulatory and operational readiness.

Conclusion

Molecular imaging CROs now play a central role in generating robust clinical evidence for complex studies. Effective partner selection, quality governance, and operational resilience will define competitive advantage as the market continues to advance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Molecular Imaging CRO Market, by Imaging Modality
8.1. MRI
8.2. Optical Imaging
8.2.1. Bioluminescence Imaging
8.2.2. Fluorescence Imaging
8.3. PET
8.3.1. Clinical PET
8.3.2. Preclinical PET
8.4. SPECT
8.4.1. Clinical SPECT
8.4.2. Preclinical SPECT
9. Molecular Imaging CRO Market, by Application
9.1. Cardiology
9.1.1. Heart Failure Imaging
9.1.2. Myocardial Perfusion Imaging
9.2. Inflammation
9.2.1. Autoimmune Imaging
9.2.2. Infection Imaging
9.3. Neurology
9.3.1. Alzheimer's Imaging
9.3.2. Parkinson's Imaging
9.4. Oncology
9.4.1. Hematological Tumor Imaging
9.4.2. Solid Tumor Imaging
10. Molecular Imaging CRO Market, by Service Type
10.1. Data Analysis
10.2. Imaging Services
10.3. Radiotracer Development
11. Molecular Imaging CRO Market, by End User
11.1. Academic Research Institutes
11.2. Contract Research Organizations
11.3. Hospitals & Diagnostic Centers
11.4. Pharmaceutical Biotech
12. Molecular Imaging CRO Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Molecular Imaging CRO Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Molecular Imaging CRO Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Molecular Imaging CRO Market
16. China Molecular Imaging CRO Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. ABX-CRO Advanced Pharmaceutical Services, LLC
17.6. Bioclinica, Inc.
17.7. Biomedical Systems Corporation
17.8. Biospective, Inc.
17.9. Biotrial, SA
17.10. Blue Earth Diagnostics Ltd.
17.11. Charles River Laboratories International, Inc.
17.12. Crown Bioscience, Inc.
17.13. Gubra A/S
17.14. ICON plc
17.15. Image Analysis Group, LLC
17.16. Imaging Endpoints, Inc.
17.17. IQVIA Holdings Inc.
17.18. Labcorp Drug Development, Inc.
17.19. Medpace Holdings, Inc.
17.20. Micron, Inc.
17.21. Oncodesign SA
17.22. Parexel International Corporation
17.23. Serac Life Sciences, Inc.
17.24. Tracer CRO, LLC
List of Figures
FIGURE 1. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MOLECULAR IMAGING CRO MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MOLECULAR IMAGING CRO MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA MOLECULAR IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY FLUORESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY FLUORESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY FLUORESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CLINICAL PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CLINICAL PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CLINICAL PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PRECLINICAL PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PRECLINICAL PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PRECLINICAL PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CLINICAL SPECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CLINICAL SPECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CLINICAL SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PRECLINICAL SPECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PRECLINICAL SPECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PRECLINICAL SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HEART FAILURE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HEART FAILURE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HEART FAILURE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY AUTOIMMUNE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY AUTOIMMUNE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY AUTOIMMUNE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFECTION IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFECTION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY INFECTION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ALZHEIMER'S IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ALZHEIMER'S IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ALZHEIMER'S IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PARKINSON'S IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PARKINSON'S IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PARKINSON'S IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HEMATOLOGICAL TUMOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HEMATOLOGICAL TUMOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HEMATOLOGICAL TUMOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SOLID TUMOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SOLID TUMOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SOLID TUMOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY RADIOTRACER DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY RADIOTRACER DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY RADIOTRACER DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 152. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 153. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 154. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 175. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 176. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 177. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 178. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 180. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 181. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 200. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 201. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 202. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 203. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 206. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 207. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. ASEAN MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 212. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 213. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 214. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 215. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 217. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 218. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 219. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 220. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 221. GCC MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 236. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 237. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 238. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 239. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 241. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 242. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 243. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 244. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 245. BRICS MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 248. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 249. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 250. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 251. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 253. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 254. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 255. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 256. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 257. G7 MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 260. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 261. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 262. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 263. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 265. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 266. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 267. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 268. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 269. NATO MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL MOLECULAR IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. CHINA MOLECULAR IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 285. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
TABLE 286. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 287. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 288. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 290. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY INFLAMMATION, 2018-2032 (USD MILLION)
TABLE 291. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 292. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 293. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 294. CHINA MOLECULAR IMAGING CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Molecular Imaging CRO market report include:
  • ABX-CRO Advanced Pharmaceutical Services, LLC
  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biospective, Inc.
  • Biotrial, SA
  • Blue Earth Diagnostics Ltd.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Gubra A/S
  • ICON plc
  • Image Analysis Group, LLC
  • Imaging Endpoints, Inc.
  • IQVIA Holdings Inc.
  • Labcorp Drug Development, Inc.
  • Medpace Holdings, Inc.
  • Micron, Inc.
  • Oncodesign SA
  • Parexel International Corporation
  • Serac Life Sciences, Inc.
  • Tracer CRO, LLC

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.7 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.84 Billion
Compound Annual Growth Rate17.1%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Oncology Based In-Vivo CRO Market - Global Forecast 2026-2032 - Product Image

Oncology Based In-Vivo CRO Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Imaging CRO Market - Global Forecast 2026-2032 - Product Image

Imaging CRO Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From
In-Vivo CRO Market - Global Strategic Business Report - Product Image

In-Vivo CRO Market - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Oncology Based In-vivo CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Oncology Based In-vivo CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.